teva glp 1 wins US obesity approval for its GLP-1 generic liraglutide | News 1 Support helps support appetite control 𝗚𝗟𝗣-𝟭 𝗮𝗽𝗽𝗿𝗼𝘃𝗮𝗹𝘀 𝗼𝗻 𝘁𝗵𝗲 𝗺𝗼𝘃𝗲

All DPP4i are more selective for DPP4 compared to other enzymes in the same family, such as FAP, DPP8, and DPP9, with selectivity ranging from less than 100fold for vildagliptin and saxagliptin to more than 14 000fold for alogliptin [66]

In addition, covalent attachment to albumin may also prolong the peptides circulation time by a unique albumin recycling pathway through the neonatal Fc receptor (FcRn) [75]

These GLP-1 receptor agonists can be categorized as either short-acting compounds, which provide short-lived receptor activation (such as exenatide and lixisenatide) or as long-acting compounds (for example albiglutide, dulaglutide, exenatide long-acting release, and liraglutide), which activate the GLP-1 receptor continuously at their recommended dose

10.1111/j.1728-4465.2010.00250.x [DOI] [PubMed] [Google Scholar] 6

In terms of weight loss, cotadutide 200 g produced effects similar to liraglutide, while the 300-g dose resulted in greater weight reduction